<DOC>
	<DOCNO>NCT00725374</DOCNO>
	<brief_summary>The primary purpose study compare change expression proliferation marker Ki-67 malignant breast tissue treatment tibolone placebo postmenopausal woman need undergo surgery primary breast cancer</brief_summary>
	<brief_title>A Study Investigate Effects Tibolone ( LivialÂ® ) Breast Tissue Postmenopausal Women With Breast Cancer ( Study 32971 ) ( P06469 )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tibolone</mesh_term>
	<criteria>postmenopausal woman age require surgery early invasive primary breast cancer ( clinically stage I II ; T1T3 ; N01 ; M0 ) , estrogen receptorpositive tumor ( ) body mass index 18 2 kg/m2 , inclusive must willing give voluntary write informed consent . healthy subject</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>